Financing R&D and Improved Standards of Care in an Era of Strategic Realignment (Invite only)

The pace and complexity of the evolving healthcare landscape demand financing models that are more collaborative and resilient than those that depend primarily on government funding. As demand for research and founder talent grows, science R&D is being reshaped by new actors, new incentives, and new capital structures. How can public- and private-sector partners build financing models that keep high-impact R&D moving from early-stage discovery to translation and adoption? What partnerships, pooled vehicles, and incentive structures can support young scientists, help doctors and hospitals deliver higher standards of care, sustain research capacity, leverage technology, and turn breakthroughs into real impact worldwide?